HSBC Holdings
ROIV icon

HSBC Holdings’s Roivant Sciences ROIV Stock Holding History

HSBC Holdings’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.32M Buy
149,600
+139,880
+1,439% +$4.13M ﹤0.01% 1193
2026
Q1 		$273K Sell
9,720
-31,577
-76% -$811K ﹤0.01% 2487
2025
Q4 		$896K Buy
+41,297
New +$815K ﹤0.01% 1997
2023
Q1 		– Sell
-11,834
Closed -$92.6K – 2989
2022
Q4 		$92.6K Sell
11,834
-12,358
-51% -$68.7K ﹤0.01% 2918
2022
Q3 		$79K Sell
24,192
-8,175
-25% -$31.7K ﹤0.01% 2773
2022
Q2 		$137K Buy
32,367
+17,683
+120% +$70.2K ﹤0.01% 2976
2022
Q1 		$71K Buy
14,684
+2,978
+25% +$19.6K ﹤0.01% 3171
2021
Q4 		$118K Buy
+11,706
New +$97.4K ﹤0.01% 3119

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

HSBC Holdings's ROIV Position: Q2 2026 in Review

HSBC Holdings increased its Roivant Sciences (ROIV) stake by 1,439% in Q2 2026, buying an estimated $4.13M and bringing the position to 149,600 shares worth $5.32M. The position accounts for ﹤0.01% of the portfolio, ranked #1193.

HSBC Holdings first reported a position in ROIV in Q4 2021 and has held it in 8 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • HSBC Holdings held 149,600 shares of Roivant Sciences worth $5.32M as of Q2 2026.
  • HSBC Holdings bought 139,880 Roivant Sciences shares in Q2 2026, an estimated $4.13M.
  • Roivant Sciences made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #1193 holding.
  • HSBC Holdings first reported a position in Roivant Sciences in Q4 2021 and has held it in 8 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.